Cardlytics, Inc. (FRA:CYX)

Cardlytics Statistics

Total Valuation

Cardlytics has a market cap or net worth of EUR 55.33 million. The enterprise value is 208.00 million.

Market Cap	55.33M
Enterprise Value	208.00M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	54.06M
Shares Outstanding	n/a
Shares Change (YoY)	+15.02%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	2.82%
Owned by Institutions (%)	32.54%
Float	47.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.26
PB Ratio	-13.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.20
EV / Sales	0.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-185.02

Financial Position

The company has a current ratio of 1.14

Current Ratio	1.14
Quick Ratio	1.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-167.88
Interest Coverage	-4.97

Financial Efficiency

Return on equity (ROE) is -341.04% and return on invested capital (ROIC) is -12.25%.

Return on Equity (ROE)	-341.04%
Return on Assets (ROA)	-9.00%
Return on Invested Capital (ROIC)	-12.25%
Return on Capital Employed (ROCE)	-29.46%
Revenue Per Employee	583,315
Profits Per Employee	-257,378
Employee Count	454
Asset Turnover	0.73
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-69.87%
50-Day Moving Average	1.57
200-Day Moving Average	1.47
Relative Strength Index (RSI)	39.14
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.15

Income Statement

In the last 12 months, Cardlytics had revenue of EUR 214.08 million and -94.46 million in losses. Loss per share was -1.81.

Revenue	214.08M
Gross Profit	94.99M
Operating Income	-42.46M
Pretax Income	-94.46M
Net Income	-94.46M
EBITDA	-21.17M
EBIT	-42.46M
Loss Per Share	-1.81

Balance Sheet

The company has 37.47 million in cash and 188.73 million in debt, giving a net cash position of -151.26 million.

Cash & Cash Equivalents	37.47M
Total Debt	188.73M
Net Cash	-151.26M
Net Cash Per Share	n/a
Equity (Book Value)	-4.01M
Book Value Per Share	-0.07
Working Capital	14.50M

Cash Flow

In the last 12 months, operating cash flow was -631,554 and capital expenditures -492,629, giving a free cash flow of -1.12 million.

Operating Cash Flow	-631,554
Capital Expenditures	-492,629
Free Cash Flow	-1.12M
FCF Per Share	n/a

Margins

Gross margin is 44.37%, with operating and profit margins of -19.84% and -44.12%.

Gross Margin	44.37%
Operating Margin	-19.84%
Pretax Margin	-44.12%
Profit Margin	-44.12%
EBITDA Margin	-9.89%
EBIT Margin	-19.84%
FCF Margin	n/a

Dividends & Yields

Cardlytics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.02%
Shareholder Yield	-15.02%
Earnings Yield	-170.70%
FCF Yield	-2.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cardlytics has an Altman Z-Score of -6.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.05
Piotroski F-Score	3